Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Carcinoma, Non-Small-Cell Lung"
topic_facet:"Phase: Phase 1, Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2C+Phase+2%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2C+Phase+2%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2C+Phase+2%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (298)
1
A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC : A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies : Phase I/II Study of the Safety, Pharmacokinetics, and Preliminary Clinical Activity of BT8009 in Patients With Nectin-4 Expressing Advanced Malignancies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC : Phase I/II, Open-label, Dose Escalation and Dose Expansion Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer : Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study : A Multiarm, Open-label, Multicenter, Phase 1b/2 Study to Evaluate Novel Combination Therapies in Subjects With Previously Treated Advanced EGFRm NSCLC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Study of RO7515629 in Participants With HLA-G Positive Solid Tumors : An Open-Label, Multicenter, Phase 1 Study to Evaluate Safety, Pharmacokinetics, and Preliminary Anti-Tumor Activity of RO7515629 in Participants With Unresectable and/or Metastatic HLA-G Positive Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Prophylactic Peptide Vaccine in Advanced ALK+ NSCLC : Pilot Study of a Prophylactic Peptide Vaccine in Advanced ALK+ NSCLC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) : A Phase 1/2 Study of LY3537982 in Patients With KRAS G12C-Mutant Advanced Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation : A Phase Ib/II, Open-Label, Multicenter Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib in Combination With Other Anti-Cancer Therapies in Patients With Previously Untreated Advanced Or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
First-In-Human Study of STX-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations : First-In-Human Study of STX-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[30]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Carcinoma, Non-Small-Cell Lung
Filter aufheben
Thema: Phase: Phase 1, Phase 2
Medienart
298
Aufsätze
298
E-Artikel
298
E-Ressourcen
Zeitschriftentitel
298
ClinicalTrials.gov
Thema
298
610
Carcinoma, Non-Small-Cell Lung
Phase: Phase 1, Phase 2
298
Study Type: Interventional
186
Lung Neoplasms
146
Recruitment Status: Recruiting
48
Carcinoma
47
Recruitment Status: Completed
44
Recruitment Status: Active, not recruiting
35
Recruitment Status: Terminated
33
Neoplasms
23
Colorectal Neoplasms
20
Recruitment Status: Not yet recruiting
18
Melanoma
11
Carcinoma, Renal Cell
11
Triple Negative Breast Neoplasms
10
Breast Neoplasms
10
Mesothelioma
10
Ovarian Neoplasms
9
Adenocarcinoma
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
114
2024
122
2023
47
2022
15
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
298
Englisch
Haven't found what you're looking for?
Wird geladen...